yahoo_financeOriginal article
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
ConferenceForalumabNeutral
AI Analysis
Summary
Tiziana Life Sciences will present Phase 2a data on intranasal foralumab from its BANYAN clinical trial at the ALS Nexus 2026 conference.
Clinical Trial Data
Phase
2a
Outcome Details
Poster presentation at ALS Nexus 2026
Importance:3/10
Sentiment:
0.10
Phase 2aintranasalALSconference presentationBANYAN trial
Related Companies
Read the original article
Published by yahoo_finance on August 24, 2026 11:00 AM